exit_to_appLogin
forum

MARKSANS Share Price Discussion

Marksans Pharma Ltd.
Sector: Pharmaceuticals and health care
... Read more
MARKSANS Share Price *
15.55 -0.25 (-1.58%)
* (quote may be delayed)

MARKSANS Discussion Forum

NewsBot @newsbot
 in 
MARKSANS
•
Jun 6 10:08 PM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
MARKSANS
•
Jun 6 9:38 PM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
MARKSANS
•
Mar 7 7:52 PM
Like
reply
Reply
share
Share
Rahul Chaudhary @chaudhary
 in 
MARKSANS
•
Feb 11 1:39 PM
Marksans Pharma reported better than street estimates of Q3 results. Company reported Q3 net profit Rs251.3mn (up 44% YoY), EBITDA margin 14.5% vs 13.2% (QoQ) and sales Rs2.48bn (up 14% YoY)
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
MARKSANS
•
Nov 17 10:47 PM
Like
reply
Reply
share
Share

  • MARKSANS - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization1,295.43
    Enterprise Value1,361.58
    Price to Earnings104.22
    Price to Book Value3.02
    Return on Capital Employed0.05
    Return on Equity0.03
    Face Value1
    Dividend YieldNA

  • MARKSANS Share Price - Technicals

    keyboard_arrow_down
    MARKSANS - 52 Week High₹38.3
    MARKSANS - 52 Week Low₹11.4

  • MARKSANS - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    11-Jun-18CentrumHold31
    22-Feb-18CentrumBuy55
    30-Sep-16Dynamic LevelsBuy70
    29-Sep-16CentrumBuy60
    View all MARKSANS - Share Targets - Broker Reports

  • MARKSANS Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 1615.416.215.0515.55
    Sep 1315.916.0515.2515.8
    Sep 1216.616.815.6515.9
    Sep 1115.916.815.716.55
    Sep 914.416.1514.315.65

  • MARKSANS Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹14.72
    30 Day Moving Average₹15.33
    50 Day Moving Average₹16.35
    100 Day Moving Average₹19.36
    200 Day Moving Average₹22.84

  • MARKSANS - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue294.66215.840.37
    Operating Profit36.4524.190.51
    Profit Before Tax16.6512.580.32
    Net Income12.4312.230.02

  • MARKSANS - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds428.97430.03-0
    Total Liabilities127.28128.45-0.01
    Total Assets556.25547.480.02

  • MARKSANS - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity23.17-18.67-2.24
    Cash from Investing Activity-7.52-7.8-0.04
    Cash from Financing Activity-17.525.9-1.68
    Net Cash Flow-1.85-0.572.25

  • MARKSANS - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.020.02
    Return on Equity0.030.03
    Return on Capital Employed0.050.03

  • MARKSANS - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.27
    3 Year CAGR Growth in Operating Profit-0.69
    3 Year CAGR Growth in EBIDTA-0.69
    3 Year CAGR Growth in Net Income-0.81
    3 Yr CAGR Growth - Diluted EPS-0.82

  • MARKSANS - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.53
    5 Year CAGR Growth in Operating Profit-0.18
    5 Year CAGR Growth in EBIDTA-0.24
    5 Year CAGR Growth in Net Income-0.69
    3 Yr CAGR Growth - Diluted EPS-0.71

  • MARKSANS Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Jun 6 10:08 PM
    NewsBot
    Jun 6 9:38 PM
    NewsBot
    Mar 7 7:52 PM
    NewsBot
    Nov 17 10:47 PM

  • MARKSANS - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
HelpAboutPrivacyTermsDisclaimersRefunds